Adam Feuerstein ✡️(@adamfeuerstein) 's Twitter Profileg
Adam Feuerstein ✡️

@adamfeuerstein

Reporter @statnews. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. #COYS. Said one analyst: The likes of Adam Feuerstein attack viciously.

ID:102094857

linkhttp://www.statnews.com calendar_today05-01-2010 15:58:41

79,4K Tweets

114,3K Followers

750 Following

Adam Feuerstein ✡️(@adamfeuerstein) 's Twitter Profile Photo

Activist investor Alex Denner, Bioverativ shareholder reach tentative settlement in insider trading case statnews.com/2024/04/29/ale…

Denner had been accused of using his position as a Bioverativ board member to make nearly $50 million from insider trading in connection with the

account_circle
Adam Feuerstein ✡️(@adamfeuerstein) 's Twitter Profile Photo

It's amazing -- and quite sad -- to see Alzheimer's disease attract the worst in biotech. $ANVS $BIVI $SAVA

Edited: $AVXL, too!

Patients exploited. Investors bamboozled.

account_circle
Adam Feuerstein ✡️(@adamfeuerstein) 's Twitter Profile Photo

Sorry, sorry, I was away from this platform and didn't see the $ANVS bullshit data dump.

A big fail and so much spin, as expected.

account_circle
Adam Feuerstein ✡️(@adamfeuerstein) 's Twitter Profile Photo

Another Enhertu win for $DSNKY $AZN

daiichisankyo.us/press-releases…

Enhertu is rewriting the rules of breast cancer diagnosis and treatment.

account_circle
Adam Feuerstein ✡️(@adamfeuerstein) 's Twitter Profile Photo

Sunday story from me. Important enough not to wait for Monday. $MOR $NVS

New, serious safety risk related to MorphoSys’ cancer drug complicates, potentially threatens, Novartis acquisition statnews.com/2024/04/28/mor…

account_circle
STAT(@statnews) 's Twitter Profile Photo

Attention early-career journalists! STAT is extending applications for the Sharon Begley Science Reporting Fellowship by one week. The deadline is now Friday, May 3. KSJ at MIT trib.al/L3F92qD

account_circle
Adam Feuerstein ✡️(@adamfeuerstein) 's Twitter Profile Photo

This week's Biotech Scorecard newsletter:

- Profiting from ‘legal’ insider trading isn’t always easy. A look at 2024 PIPE performance.
- Benitec Biopharma $BNTC: A gene therapy for OPMD improves swallowing. Single patient, so far. More data coming.
- More watercooler chatter

account_circle
Adam Feuerstein ✡️(@adamfeuerstein) 's Twitter Profile Photo

Early tests of H5N1 prevalence in milk suggest U.S. bird flu outbreak in cows is widespread statnews.com/2024/04/25/h5n… via Megan Molteni

account_circle
Adam Feuerstein ✡️(@adamfeuerstein) 's Twitter Profile Photo

Amid layoffs and a hit to earnings, Bristol’s $BMY new CEO shares his vision for the future statnews.com/2024/04/25/bri…

Bristol CEO Chris Boerner spoke to STAT's Matthew Herper

account_circle
Adam Feuerstein ✡️(@adamfeuerstein) 's Twitter Profile Photo

This is terribly sad news. Stephen was so knowledgeable and incredibly generous with his time. My condolences to his family.

Madrigal Statement on the Passing of Dr. Stephen Harrison globenewswire.com/news-release/2…

account_circle
Adam Feuerstein ✡️(@adamfeuerstein) 's Twitter Profile Photo

Biogen’s $BIIB Alzheimer’s drug launch on ‘steady pace’ as logistical hurdles recede statnews.com/2024/04/24/bio…

Also, Viehbacher's comments re: M&A

account_circle
Elaine Chen(@elaineywchen) 's Twitter Profile Photo

Two reports out this morning show spending on GLP-1 drugs have surged, and is set to climb still more this year and beyond.

Health entities spent $38.6 billion on Ozempic/Wegovy last year (double the year before), making it the top-seller among all drugs
statnews.com/2024/04/24/wei…

account_circle
Adam Feuerstein ✡️(@adamfeuerstein) 's Twitter Profile Photo

Massive amounts of H5N1 vaccine would be needed if there’s a bird flu pandemic. Can we make enough? statnews.com/2024/04/24/h5n… via Helen Branswell 🇨🇦

account_circle